Sentence examples for an efficacy test of from inspiring English sources

If in an efficacy test of an antiseptic product, neutralization validation is performed with a very short storage time after sampling, and the efficacy test itself has a long storage time after sampling, this may well result in a lower number of surviving test organisms indicating better efficacy of the antiseptic product which could be classified as a false-positive efficacy result.

However, data on the range of concentrations and durations of application providing a basis for passing the efficacy test of the European norm EN 12791 are still lacking.

Marzi, A. et al. Stat1-deficient mice are not an appropriate model for efficacy testing of recombinant vesicular Stomatitis virus-Based Filovirus Vaccines.

Reported data from lung-function testing provide a unique opportunity for pre-clinical efficacy testing of anti-inflammatory substances in a relatively inexpensive translational NHP model.

This paper describes the development and protocol for feasibility and efficacy testing of a risk reduction intervention designed to improve behavioral health outcomes among drug offenders on probation under community supervision or in residential substance abuse treatment centers.

The Animal Rule allows for efficacy testing of a vaccine to be performed exclusively using relevant animal models of tularemia provided that its mechanism of action in such models predicts its efficacy in humans.

In vivo ocular anti-inflammatory efficacy test confirmed an optimal efficacy of NPs and its potential application in eye surgery.

Thus, the subtype C HIV vaccine regimen qualified for phase 2b/3 efficacy testing, a critical next step of vaccine development.

A negative CRM may provide an early surrogate test of efficacy and a predictor of local recurrence, enabling the rapid evaluation of the many new treatment regimens currently being investigated (Cunningham et al, 2002).

This study was the first to test the efficacy of AMA-1; subjected to a stringent test of efficacy that required treatment at time of proven patency, no vaccine formulation prevented infection or delayed patency, but one formulation, AMA-1/AS02A, did suggest a significant reduction in parasite burden as determined by PCR analysis.

Neither of these two studies had a reference compound, and so it could not be determined whether the drug failed or the study failed as an adequate test of efficacy.